Rapidtests.org is an example of how a group of concerned citizens can form to address a critical challenge, in this case the need for rapid tests for COVID-19. The group is attracting highly skilled and informed citizens from across the US who see the potential of an inexpensive fast self-test to change the direction of the COVID disaster that is destroying the global economy.
Author: Brett Johnson
Sherlock Biosciences, launched March of 2019, is an early-stage venture whose focus is to “develop affordable, instrument-free diagnostic tests for use in oncology and infectious diseases, as well as in industrial and agricultural applications. SHERLOCK is an evolution of CRISPR technology, which others use to make precise edits in genetic code. SHERLOCK can detect the unique genetic fingerprints of virtually any DNA or RNA sequence in any organism or pathogen. Developed by our founders and licensed exclusively from the Broad Institute, SHERLOCK is a method for single molecule detection of nucleic acid targets and stands for Specific High Sensitivity Enzymatic Reporter…
DecomBio, incorporated in California, consists of a multidisciplinary team of researchers and physicians at UCSF and UC Berkeley. They specialize in assembling, packaging and distributing colloidal gold diagnostic instruments in North America. Their product received acknowledgment from the U.S. FDA, with permission to distribute. [mepr-show rules=”18700″ unauth=”message”] DecomBio’s Noval Coronavirus (SARS- COV-2) IgM/IgG Combo Rapid Test uses Whole blood, serum, or plasma to direct the presence of the virus. The test can be used at home or administered by a healthcare professional and results are available in 20 minutes. The FDA has approved the test and is in the final stages of EUA…
Since 1990, Aurora has been serving the global scientific research community through the development of innovative laboratory solutions. The company started manufacturing analytical instrumentation based on a patented capacitively coupled plasma emission technology.The organization develops laboratory solutions, analytical instrumentation, and automated liquid handling platforms. [mepr-show rules=”18700″ unauth=”message”] Aurora Biomed developed its anitbody COVID-19 IgM/IgG Rapid Test Kit which can measure results in 10-15 minutes. The test uses Human serum, plasma, or whole blood and can be administered at home or under the supervision of medical personel. It is currently in development and price is available upon request. Aurora is a privately owned company and in 2000, Aurora became the first to develop…
BioSURE is a UK company specializing in the provision of rapid in-vitro diagnostic testing solutions. The BioSURE COVID-19 Self-Test will be an at-home antibody test that will use technology similar to that of a pregnancy test. The lateral flow chromatography assay test will detect the presence of IgG antibodies to the COVID-19 virus, not COVID-19 itself. The BioSURE COVID-19 Self-Test will be as easy as 3 simple steps. Prick, Suck and Poke. The finger-prick blood sample will provide results in 11 minutes. [mepr-show rules=”18700″ unauth=”message”] The BioSURE COVID-19 Self-Test was developed in partnership with Mologic, a leading developer of lateral flow and rapid diagnostic technologies,…
Market Overview was prepared by a team from Cambridge University. The objective was understanding of the testing market in Europe. The report also offers insight into Asia. The 50 page deck examined the COVID testing market broadly and assessed a variety of market dynamics: Market size for PCR and Antibody tests The different business models employed Regulatory pathways Supply chain analysis including bottlenecks. Regulatory landscape. Including a detailed flow chart analyzing zing the complexity of approval process in the EU, China and South Korea. Also included was the commercialization landscape and the reimbursement analysis for France, Germany, UK, Spain and…
The Thesis: A tremendous wealth of innovative science is occurring at Universities and among individual scientists and inventors. If such innovation could be matched with other groups working on similar problems and projects, great advances and even breakthroughs could be accelerated. Furthermore if such breakthroughs could be matched with commercialization strategies, solutions to complex challenges like pandemics and climate change could be found. But today no such collaborative model exists broadly. Scientists do collaborate but only through their own initiatives and our institutions are not designed to reward such collaboration. In fact, the incentive systems currently in place discourage it.…
Extensive Study in the UK involving 1,700 patients showed consistent benefits from steroid treatment. A new analysis of several studies in the UK which steroid drugs were used to determine effectiveness for treating COVID-19 found that they significantly reduced patient deaths, bolstering early, preliminary evidence for the benefit of these medications. Key Findings: In numerous studies 1700 participants received corticosteroids an anti-inflammatory drug that can damp the effects of an overactive Immune System. The results showed a reduction in the death rate by almost one third, compared with patients who did not receive the treatment. Scientists and physicians convened by…